Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
暂无分享,去创建一个
Katya Galactionova | Mark Jit | Melissa A Penny | Thomas A Smith | Azra C Ghani | Robert Verity | Stefan Flasche | Thomas A. Smith | Christophe Sauboin | M. Jit | R. Verity | A. Ghani | J. Griffin | P. Eckhoff | E. Wenger | M. Penny | M. White | S. Flasche | C. Bever | Jamie T Griffin | Edward A Wenger | Philip A Eckhoff | P. Pemberton-Ross | Caitlin A Bever | Michael T White | Nicolas Van de Velde | Peter Pemberton-Ross | Farzana Muhib | C. Sauboin | Katya Galactionova | F. Muhib | K. Galactionova | N. Van de Velde | Farzana Muhib
[1] R. Snow,et al. Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[2] B. Greenwood,et al. Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites , 2014, PLoS medicine.
[3] Neil M Ferguson,et al. Modelling the impact of vector control interventions on Anopheles gambiae population dynamics , 2011, Parasites & Vectors.
[4] M. Tanner,et al. Age Interactions in the Development of Naturally Acquired Immunity to Plasmodium falciparum and Its Clinical Presentation , 2007, PLoS Medicine.
[5] P. Eckhoff,et al. A mathematical model of the impact of present and future malaria vaccines , 2013, Malaria Journal.
[6] A. Ghani,et al. Loss of Population Levels of Immunity to Malaria as a Result of Exposure-Reducing Interventions: Consequences for Interpretation of Disease Trends , 2009, PloS one.
[7] Mohsen Naghavi,et al. GBD 2010: design, definitions, and metrics , 2012, The Lancet.
[8] Alan Brooks,et al. Modeling the public health impact of malaria vaccines for developers and policymakers , 2013, BMC Infectious Diseases.
[9] Kwaku Poku Asante,et al. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial , 2015 .
[10] D. Conway,et al. Dynamics of the antibody response to Plasmodium falciparum infection in African children. , 2014, The Journal of infectious diseases.
[11] R. Snow,et al. Malaria transmission and morbidity. , 1999, Parassitologia.
[12] Yuming Guo,et al. The effect of air pollution on human physiological function in China: a longitudinal study , 2015, The Lancet.
[14] R. Hutubessy,et al. Decision-making on malaria vaccine introduction: the role of cost-effectiveness analyses. , 2012, Bulletin of the World Health Organization.
[15] B. Sharp,et al. Malaria Journal BioMed Central Research Costs and consequences of large-scale vector control for malaria , 2022 .
[16] J. Cox,et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. , 2005, JAMA.
[17] F. Tediosi,et al. The costs of introducing a malaria vaccine through the expanded program on immunization in Tanzania. , 2006, The American journal of tropical medicine and hygiene.
[18] Katya Galactionova,et al. The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models , 2015, BMC Medicine.
[19] A. Ghani,et al. Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants? , 2008, Malaria Journal.
[20] Amanda Ross,et al. An epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparum. , 2006, The American journal of tropical medicine and hygiene.
[21] R. Hutubessy,et al. Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal , 2011, BMC medicine.
[22] Andrew J Tatem,et al. The global distribution and population at risk of malaria: past, present, and future. , 2004, The Lancet. Infectious diseases.
[23] R. Cibulskis,et al. Achieving the malaria MDG target: Reversing the incidence of malaria 2000-2015. , 2015 .
[24] R. Snow,et al. The burden of malaria mortality among African children in the year 2000. , 2006, International journal of epidemiology.
[25] Thomas A. Smith,et al. The effect of malaria transmission intensity on neonatal mortality in endemic areas. , 2006, The American journal of tropical medicine and hygiene.
[26] Simon I Hay,et al. Defining the relationship between Plasmodium falciparum parasite rate and clinical disease: statistical models for disease burden estimation , 2009, Malaria Journal.
[27] Thomas A. Smith,et al. Age-shifting in malaria incidence as a result of induced immunological deficit: a simulation study , 2015, Malaria Journal.
[28] Kevin A McCarthy,et al. Calibration of an intrahost malaria model and parameter ensemble evaluation of a pre-erythrocytic vaccine , 2014, Malaria Journal.
[29] Gerry Killeen,et al. Relationships between host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum. , 2006, The American journal of tropical medicine and hygiene.
[30] Penelope Vounatsou,et al. Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. , 2006, The American journal of tropical medicine and hygiene.
[31] M. Tanner,et al. Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission , 1996, Tropical medicine & international health : TM & IH.
[32] Thomas Smith,et al. A Periodically-Forced Mathematical Model for the Seasonal Dynamics of Malaria in Mosquitoes , 2012, Bulletin of mathematical biology.
[33] Gao Qi,et al. Global technical strategy for malaria 2016–2030 , 2015 .
[34] P. Eckhoff,et al. Malaria parasite diversity and transmission intensity affect development of parasitological immunity in a mathematical model , 2012, Malaria Journal.
[35] P. Eckhoff. A malaria transmission-directed model of mosquito life cycle and ecology , 2011, Malaria Journal.
[36] C. Rogier,et al. Combating malaria morbidity and mortality by reducing transmission. , 1996, Parasitology today.
[37] A. Ghani,et al. Gradual acquisition of immunity to severe malaria with increasing exposure , 2015, Proceedings of the Royal Society B: Biological Sciences.
[38] Chris Sugden,et al. Partnership , 1997, The Fairchild Books Dictionary of Fashion.
[39] Chris Newbold,et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa , 1997, The Lancet.
[40] Thomas A. Smith,et al. Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[41] R. Cibulskis,et al. World Malaria Report 2013 , 2014 .
[42] Thomas Smith,et al. Comparing the Effectiveness of Malaria Vector-Control Interventions Through a Mathematical Model , 2010, The American journal of tropical medicine and hygiene.
[43] P. Eckhoff,et al. Mathematical Models of Within-Host and Transmission Dynamics to Determine Effects of Malaria Interventions in a Variety of Transmission Settings , 2013, The American journal of tropical medicine and hygiene.
[44] Wes Hinsley,et al. Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies , 2010, PLoS medicine.
[45] A. Culyer. African Health Economics and Policy Association , 2014 .
[46] Neil M. Ferguson,et al. Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa , 2014, Nature Communications.
[47] Katya Galactionova,et al. Effective Coverage and Systems Effectiveness for Malaria Case Management in Sub-Saharan African Countries , 2015, PloS one.
[48] A. Ghani,et al. Costs and cost-effectiveness of malaria control interventions - a systematic review , 2011, Malaria Journal.
[49] R. Snow,et al. Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity , 2009, Malaria Journal.
[50] David L. Smith,et al. Distribution of malaria exposure in endemic countries in Africa considering country levels of effective treatment , 2015, Malaria Journal.
[51] P. Eckhoff,et al. P. falciparum Infection Durations and Infectiousness Are Shaped by Antigenic Variation and Innate and Adaptive Host Immunity in a Mathematical Model , 2012, PloS one.
[52] Peter G. Kremsner,et al. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. , 2015 .
[53] Amanda Ross,et al. A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. , 2006, The American journal of tropical medicine and hygiene.
[54] Amanda Ross,et al. Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview. , 2006, The American journal of tropical medicine and hygiene.
[55] Kwaku Poku Asante,et al. A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine , 2014, BMC Medicine.
[56] Amanda Ross,et al. An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria. , 2006, The American journal of tropical medicine and hygiene.
[58] U. Dalrymple,et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015 , 2015, Nature.
[59] N. Walker,et al. The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance. , 2013, Vaccine.
[60] J. Gerardin,et al. Fun with maths: exploring implications of mathematical models for malaria eradication , 2014, Malaria Journal.
[61] Thomas Smith,et al. Ensemble Modeling of the Likely Public Health Impact of a Pre-Erythrocytic Malaria Vaccine , 2012, PLoS medicine.
[62] C. Lengeler,et al. Insecticide-treated bed nets and curtains for preventing malaria. , 2004, The Cochrane database of systematic reviews.
[63] Kevin Marsh,et al. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. , 2013, The New England journal of medicine.
[64] Alan D. Lopez,et al. The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .
[65] M. Tanner,et al. Age-Patterns of Malaria Vary with Severity, Transmission Intensity and Seasonality in Sub-Saharan Africa: A Systematic Review and Pooled Analysis , 2010, PloS one.
[66] David L. Smith,et al. A World Malaria Map: Plasmodium falciparum Endemicity in 2007 , 2009, PLoS medicine.